Hypoxia, a hallmark of solid tumors, and high expression of HIF‐1α in human cancers are associated with poor patient prognosis and response to radiotherapy.[46] As a result, HIF‐1α is considered to be a high potential therapeutic target, and blocking HIF‐1α may be a promising strategy for the treatment of cancer. This evidence concerns the gene HIF1A and cancer.